DSS India – Drug Safety Symposium
Days
Hours
Minutes
Seconds

Our Commitment

Your perception is our reality, that’s what makes us different! Here’s what we do to deliver exceptional content.

Global Thought Leadership

Our conference brings together the leading experts, thought leaders and regulators to provide unparalleled insights into the latest trends and challenges shaping the industry.

Interactive Learning

Our unique approach ensures a holistic and engaging experience for our attendees. Our conferences are not just about passive listening; it's about active participation. Gain practical insights and actionable takeaways that you can apply immediately in your role.

Cutting-Edge Technology

Explore the latest technological advancements and software solutions that are transforming pharmacovigilance practices, offering efficiency and compliance.

Regulatory Insights

Gain direct access to regulatory authorities and compliance experts who provide valuable insights into regional and international pharmacovigilance regulations.

Speakers

Founder

Pvigilant Health

Dr. Ahmed Hegazy

 

General Manager

Serum Institute of

India Pvt. Ltd

Dr. Chetanraj G Bhamare

 

Heads Global Pharmacovigilance and Clinical Operations

Arcolab

Dr. Gopal Muralidharan

Multi-Country Safety Head
for South Asia & Indo-China

Sanofi India

Dr. Jamal Baig

Director – Global Patient Safety & Pharmacovigilance,

Novartis

Mr. Mukesh Gori

Global Head – PV

Alkem Laboratories

Dr. Rahul Somani

 

Sr. Vice President

and Medical Director

Hetero

Dr. Shubhadeep Debabrata Sinha

Event Partners

GOLD PARTNER

Arcolab is a global life science consulting and technology partner, designed to provide diverse capabilities and services with subject matter experts across domains. Arcolab is ISO 27001 & ISO 27701 certified, assuring customers that the implemented controls are effective and aligned with the highest standards of data security and privacy.
With over 500 employees, we provide services to 30+ clients spanning 5 continents across life science areas, including injectables, APIs, biologics, oral dosages, medical devices and R&D centres. Our expertise spans a comprehensive range of life science services, including global pharmacovigilance, clinical operations, computer system validation, intellectual property rights, IT, quality assurance, people & digital services, and many more.

Learn More

EXHIBIT PARTNER

SafeVig Solutions is a technology-driven company specializing in pharmacovigilance (PV) automation and digitalization. Focused on revolutionizing drug safety operations, SafeVig offers next-generation platforms powered by artificial intelligence (AI), machine learning (ML), and natural language processing (NLP). Their flagship solutions streamline critical PV processes, including case processing, signal detection, and risk management, reducing manual effort and ensuring faster, more accurate safety insights. With a strong emphasis on regulatory compliance, inspection readiness, and operational excellence, SafeVig empowers pharmaceutical, biotechnology, and healthcare companies to modernize their pharmacovigilance systems, improve patient safety outcomes, and drive efficiencies across the entire product lifecycle.

Learn More

Media Partners

PAST EVENT PARTNERS

PRICING

INR 50000*

+ 18% GST applicable

USD 1800*

+ 18% GST applicable

* Pricing is applicable for Pharma Manufacturing companies only.

Partners

Why Partner at Drug Safety Symposium – India Chapter?

By partnering with us, you can position your brand at the forefront of the pharmaceutical landscape and gain invaluable exposure to a highly targeted and influential audience.

Unparalleled Visibility

Benefit from our extensive marketing efforts, including online promotion, social media campaigns, email marketing, and partnerships with industry associations.

Networking and Collaboration

Identify new business opportunities, collaborations, and partnerships that can drive growth and innovation in your organization by forging strategic alliances.

Thought Leadership

Showcase your organization's expertise by sponsoring a speaking session or panel discussion, allowing you to share insights and thought leadership.

Customized Sponsorship Packages

We offer flexible sponsorship packages that can be customized to meet your specific marketing and branding objectives. Choose from various sponsorship tiers, each offering unique benefits and levels of exposure.

Partnering with the Drug Safety Symposium is a strategic investment, to explore sponsorship opportunities and discuss customized packages, please contact us at [email protected]

India

What Can You Do In Mumbai

Gateway of India 

Juhu Beach

Prithvi Cafe

Jehangir Art Gallery

Marine Drive

Siddhivinayak Temple

Haji Ali Dargah

Mount Mary Church

Elephanta Caves

 Kanheri Caves

Advancing Excellence in Pharmaceutical Vigilance, Regulatory Affairs and Quality Assurance
Facebook Instagram Twitter Linkedin Youtube
Contact Us
Tweets From

© Copyright Eminence Group Ventures FZ CO

Scroll to Top

Dr. Ahmed Hegazy

Founder, Pvigilant Health - Dubai

Dr. Ahmed Hegazy is a seasoned physician and pharmaceutical medicine expert with over 27 years of extensive experience across sales, medical affairs, marketing, training, and pharmacovigilance in the pharmaceutical industry. He holds a Master’s degree in Pharmaceutical Medicine with First Class Honours for his thesis on Adverse Drug Reactions in the Middle East—recognized with distinction, presented at ISoP 2017, and published in Drug Safety.

His academic journey is enriched with certifications from prestigious institutions including George Washington University (Neurology), Columbia University (Immunology and Transplantation), the Royal College of Physicians (GCP & Clinical Research), Uppsala Monitoring Centre (Pharmacovigilance), and more. He also holds a Mini MBA, and diplomas in Medical Quality and Hospital Management. Additionally, he is an ISO 9001:2015 Lead Auditor (IRCA-accredited) and a Lean Six Sigma Green Belt holder.

Dr. Hegazy served as Head of Global Patient Safety at Merck for seven years, overseeing PV operations across 82 countries with a team across eight nations. His Medical Affairs leadership spans 12+ years across various therapeutic areas, including neurology, oncology, endocrinology, immunology, and infectious diseases.

He is currently the Founder of Pvigilant Health, based in Dubai, and operates as an Executive Consultant in Medical Affairs and Pharmacovigilance for local and global firms. A respected thought leader, he regularly chairs, moderates, and speaks at conferences and trains regulatory bodies, academic institutions, and industry professionals worldwide.

Drug discovery and development, Ethics, Biostatistics, Research Methodology, Regulatory Affairs, Medical Affairs, and Pharmacovigilance. His current position is Head of Global Patient Safety for Intercontinental Region (Africa, Middle East, Turkey, Russia and CIS) at Merck. I am based in Dubai, UAE and my team members are based in 7 hubs / locations across the region.

Dr. Chetanraj G Bhamare

Dy. QPPV (Asst GM) - Clinical Research & PV,
Serum Institute of India

Dr. Chetanraj G Bhamare, is a Clinical Pharmacologist with over 13 years of experience in clinical research and pharmacovigilance. He has an MBBS and post-graduation – MD in Clinical Pharmacology and Therapeutics.  Currently, he is working in the world’s largest manufacturer of vaccines, Serum Institute of India Pvt. Ltd. (SIIPL), Pune in the capacity of Safety Physician.

Since 2015, he has been working with Serum Institute of India Pvt Ltd and involved in end-to-end pharmacovigilance activities of all vaccines, biologicals, and clinical development.

He has many national and international publications to add to his credit. He is a member of the Indian Society for Clinical Research (ISCR) Pharmacovigilance Council and of the Developing Countries Vaccine Manufacturers Network (DCVMN) Pharmacovigilance Working Group.

Dr. Gopal Muralidharan

Heads Global Pharmacovigilance and Clinical Operations, Arcolab

Dr. Gopal Muralidharan heads the global pharmacovigilance and clinical operations team at Arcolab. With over 35 years of experience, he has worked in both pre-clinical and clinical research areas in the USA, for almost 15 years with American Cyanamid (Lederle Laboratories, USA) and Wyeth Research (presently Pfizer, USA). He later returned to India as President and CSO of Lotus Labs, Bangalore. As an entrepreneur, he set up a CRO and
has worked extensively in Clinical, Non-Clinical and bioanalytical areas of drug development programs across various therapeutic areas not only for NMEs (NDAs, including 505b2) but also for Generic molecules (ANDAs), with quality and integrity serving as the cornerstone of his successful contributions. He led the transformation of the pharmacovigilance program at Arcolab.
On the academic front, he served as an Adjunct Faculty at Manipal College of Pharmaceutical Sciences, Manipal University and was also a research guide to post- graduate students at the Rajiv Gandhi University of Health Sciences, Bangalore.
He has made several scientific presentations in national and international forums and has also been involved in several scientific deliberations with regulatory authorities worldwide. He has served as a consultant to the Tropical Disease Research program of the World Health Organization and is a member of several international professional organizations.
Dr. Muralidharan has a Ph.D. in Drug Metabolism and Pharmacokinetics from the University of Saskatchewan, Canada.

Dr. Jamal Baig, M. Pharm

Multi-Country Safety Head for South Asia & Indo-China Sanofi India

Dr. Jamal Baig, M. Pharm, Ph.D. (Pharmacology), is the Multi-Country Safety Head for South Asia & Indo-China at Sanofi India since November 2021, with over 16 years of experience. He previously served as the PV Head at MSD Pharmaceuticals for 11+ years and as a Team Leader at Pfizer Drug and Safety PV Process at Wipro Ltd. He has held various industry positions, including Chair of the PV Council at ISCR and member of the PV Task Force at OPPI. Dr. Baig has played a leading role in developing PV guidelines in India and is a frequent speaker at national and international PV events.

Mr. Mukesh Gori

Director – Global Patient Safety & Pharmacovigilance, Novartis

Mr. Mukesh Gori, with extensive experience in global patient safety and pharmacovigilance, serves as Director at Novartis. He excels in executing strategic visions, managing external relationships, and ensuring QMS compliance in supplier selection, qualification, and management. His responsibilities include overseeing contract management, third-party risk, governance, transitions, and budget planning for outsourcing. Mukesh facilitates leadership-level communication, providing strategic advice on Alliance operations and contributing to the Pharmacovigilance System Master File (PSMF).

He leads governance forums, manages issues, escalations, and transitions, and ensures adherence to global SOPs. Mukesh has created RFP documents, conducted vendor due diligence, and managed audits, CAPAs, and QMS processes. As a people manager, he emphasizes team retention, training, and diversity. Before Novartis, he led Operations and Vendor Management in Drug Safety at Cipla Pharma, overseeing biosimilar management and regulatory inspections.

Mukesh’s expertise in pharmacovigilance strategy and operations positions him as a leader committed to driving excellence, effective communication, and a culture of quality and compliance in all his professional endeavors.

Dr. Rahul Somani

Global Head – PV, Alkem Laboratories

I have been with Alkem Laboratories Ltd, Mumbai, for the past 13 years in various roles and am currently serving as the Head of Global Pharmacovigilance.

With 25 years of experience spanning both academic and industrial roles, I have played a key role in establishing an in-house Pharmacovigilance department that adheres to stringent regulatory standards and processes. This has supported our global pharmacovigilance operations through the development and implementation of comprehensive safety monitoring systems, risk management plans, and regulatory compliance strategies.

In the past five years, I have successfully led my team through three major regulatory inspections for Pharmacovigilance by the USFDA, TGA-Australia, and MoH-Kazakhstan. These inspections required meticulous preparation and a deep understanding of regulatory requirements, affirming the robustness and effectiveness of our pharmacovigilance practice.

Dr. Shubhadeep Debabrata Sinha

Senior Vice President and Medical Director, Hetero

Dr. Shubhadeep D. Sinha is a seasoned pharmaceutical leader and practicing physician with over 23 years of global experience across clinical development, pharmacovigilance, and medical affairs. Currently serving as Senior Vice President and Head of Global Operations at Hetero Group of Pharmaceuticals, he leads clinical trials, pharmacovigilance, medical writing, medico-regulatory functions, and product ideation for generics, biologics, and discovery molecules.

Prior to Hetero, Dr. Sinha held leadership roles at renowned organizations including Dr. Reddy’s, Glenmark, Accenture, Vimta Labs, and Indigene Alquest. His clinical development work spans a broad portfolio—from NCEs in HIV and oncology to biosimilars like Rituximab, Trastuzumab, and Tenecteplase, and generics across key therapeutic areas such as COVID-19, Hepatitis-C, cardiology, and rheumatology.

He has established and scaled global pharmacovigilance systems at multiple firms, successfully navigating USFDA and international regulatory inspections. Dr. Sinha is also a board-certified practicing physician specializing in infectious diseases and diabetology.

An accomplished academic, he has published 30 peer-reviewed articles, authored two books, and contributes as adjunct faculty at KMC Manipal and IGIMS Patna. His blend of strategic leadership and clinical insight positions him as a key voice in shaping modern drug safety and development.